636.79999 EUR
8.2
1.30%
Last update Dec 17, 5:30 PM CET
Main market
Day range
636.79999
636.79999
Previous close
628.59998
Open
636.79999
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
636.80
8.20
1.30%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2021 2020 2019
Total reported revenue 12.1B 16.1B 8.5B 7.9B
Cost of revenue 1.7B 2.4B 1.1B 782.2M
Gross profit 10.4B 13.6B 7.4B 7.1B
Operating expense
Research & development 4.5B 2.9B 2.7B 3.0B
Selling general and admin 2.5B 1.8B 1.3B 1.8B
Other operating expenses 45.5M -45.6M -280.4M
Operating income 3.4B 8.9B 3.6B 2.2B
Non operating interest income
Income 606.5M
Expense 47.1M 57.3M 56.9M 30.2M
Other income expense 113.4M 436.3M 290.7M 249.5M
Pretax income 4.1B 9.3B 3.8B 2.4B
Tax provision 313.1M 1.3B 297.2M 313.3M
Net income 3.8B 8.1B 3.5B 2.1B
Basic EPS 40.9 76.4 32.7 19.4
Diluted EPS 38.3 72.0 30.5 18.5
Basic average shares 92.0M 105.7M 107.6M 109.2M
Diluted average shares 92.0M 105.7M 107.6M 109.2M
EBITDA 4.4B 9.7B 4.1B 2.7B
Net income from continuing op. 3.8B 8.1B 3.5B 2.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 41 minutes

17:03
00:00
09:00
17:45
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 09:00
Main market
09:00 - 17:45
Post-market
17:30 - 20:30
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).